Exact Sciences Corp (EXK.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
As of 12:22PM CEST. Market open.
| Previous close | 57.76 |
| Open | 57.70 |
| Bid | 57.68 x N/A |
| Ask | 59.44 x N/A |
| Day's range | 58.09 - 58.56 |
| 52-week range | 51.34 - 94.80 |
| Volume | |
| Avg. volume | 5 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireExact Sciences to Participate in May Investor Conference
MADISON, Wis., May 01, 2024--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.
Simply Wall St.Exact Sciences Corporation's (NASDAQ:EXAS) Profit Outlook
With the business potentially at an important milestone, we thought we'd take a closer look at Exact Sciences...
Business WireExact Sciences Names Aaron Bloomer as New Chief Financial Officer
MADISON, Wis., April 15, 2024--Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024.
© 2024 Yahoo. All rights reserved.